BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
90.58
-2.27 (-2.44%)
Jul 31, 2026, 4:00 PM EDT - Market closed
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $22.91 billion as of July 31, 2026. Its market cap has decreased by -15.47% in one year.
Market Cap
22.91B
Enterprise Value
7.45B
1-Year Change
-15.47%
Ranking
Category
Stock Price
$90.58
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $22.91B, an increase of 664.82%. That is a compound annual growth rate of 34.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 22.91B | 0.07% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 35.13B |
| Royalty Pharma | 33.65B |
| Alnylam Pharmaceuticals | 27.50B |
| Roivant Sciences | 24.39B |
| Incyte | 24.23B |
| Moderna | 21.89B |
| Insmed | 21.37B |
| Genmab | 17.56B |